Sign In

A subscription to JoVE is required to view this content. Sign in or start your free trial.

In This Article

  • Summary
  • Abstract
  • Introduction
  • Protocol
  • Representative Results
  • Discussion
  • Acknowledgements
  • Materials
  • References
  • Reprints and Permissions

Summary

Here we describe the application of transcorporal artificial urethral sphincter (AUS) placement in a case requiring revision of an artificial urinary sphincter for urethral atrophy.

Abstract

Artificial urethral sphincter (AUS) implantation is the definitive management of male stress urinary incontinence (SUI). Under the long-term pressure of the cuff, recurrence of incontinence caused by urethral atrophy can always be observed in patients. In this situation, distal cuff locations are needed, and new cuff sites should be sought in patients who need to undergo AUS reimplantations. Meanwhile, the circumference of the more distal urethra is often too small to fit with a 4.0 cm cuff. This means that the bulk of the urethra should be added not only for a sufficient urethral circumference but also for better protection. Here, we report a case that required AUS reimplantation because of urethral atrophy. This 73-year-old man had undergone AUS implantation 7 years ago and developed incontinence in the past 3 months. Physical examination and ultrasonography determined that the device still worked, and no obstruction or injury was observed through cystoscopy. Surgery for revision of the AUS was needed. In this operation, a new cuff was implanted transcorporally, which was 2 to 3 cm distal to the original cuff site. During a 6 month short-term follow-up, no stress incontinence, urethral injury, or dysuria was observed. The transcorporal technique offers significant advantages in patients with urethral atrophy: corporal tunica albuginea is added to the urethra, allowing a suitable cuff size and lower risk of erosion. It is worth recommending in the reoperation of AUS implantation.

Introduction

In the past three decades, artificial urethral sphincter (AUS) implantation has been the definitive management for male stress urinary incontinence, and most patients can benefit from this technique1. However, some patients may develop recurrences of slight incontinence with time, which is usually caused by urethral atrophy beneath the cuff. Meanwhile, patients who undergo urethral surgeries or radical prostatectomy may also develop stress urinary incontinence accompanying urethral atrophy. In these situations, the original cuff sites are not suitable for simply reimplanting a downsizing cuff, and a new cuff site or a second tandem cuff implant....

Protocol

The study was approved by the local Medical Ethics Committee of Shanghai Ninth People's Hospital in China. All of the studies were conducted in accordance with the World Medical Association Declaration of Helsinki. Written consent was obtained from the patient.

1. Preparations

  1. Monitor the patient for the development of urethral injury or stricture under the long-term pressure of the original cuff through a flexible cystoscopy.
  2. Ensure that the device w.......

Representative Results

The operation went smoothly, and the patient recovered quickly. No complications, such as infection, edema, hematoma, or uroschesis, were observed. The device was activated at postoperative week 6 in the outpatient service. During a 6 month short-term follow-up, the patient could operate the AUS device expertly without stress incontinence, and no urethral injury or dysuresia occurred (Table 1).

Discussion

Artificial urinary sphincter implantation is the gold standard for the treatment of SUI, and high success and satisfactory rates have been reported7. Yafi and colleagues reported a 79% success rate and a90% satisfaction rate in their systematic review8. In the long-term follow-up, complications such as nonfunctioning devices, subcuff atrophy, erosion, and infection were reported to be common. For patients who develop subcuff atrophy or erosion, removing the original cuff an.......

Acknowledgements

This study was sponsored by Cross Disciplinary Research Fund of Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine (JYJC202103).

....

Materials

NameCompanyCatalog NumberComments
3-0 absorbable polyglatin sutureETHICONVCP311Hsuture
5-0 absorbable polyglatin sutureETHICONVC433Hsuture
Artificial urinary sphincterBoston ScientificAUS800A device for managetment of male stress urinary incontinence
Cefuroxime sodiumYoucare Parmaceutical GroupH20063758Antibiotics
Flexible cystoscopyKARL STORZC-VIEW®cystoscopy
Foley catheterHAIYAN KANGYUAN MEDICAL INSTRUMENT CO., LTD.20192140294Catheter
OrnidazolePudepharmaH20040104Antibiotics
VancomycinEli Lilly Japan K.K,Seishin LaboratoriesJX20130179Antibiotics

References

  1. Boswell, T. C., Elliott, D. S., Rangel, L. J., Linder, B. J. Long-term device survival and quality of life outcomes following artificial urinary sphincter placement. Translational Andrology and Urology. 9 (1), 56-61 (2020).
  2. Motley, R. C., Barrett, D. M.

Explore More Articles

Artificial Urinary SphincterUrethral AtrophyTranscorporal Cuff PlacementStress Urinary IncontinenceAUS ReimplantationUrethral CircumferenceTunica Albuginea

This article has been published

Video Coming Soon

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2024 MyJoVE Corporation. All rights reserved